Category Archives: News

Jazz Pharmaceuticals Announces FDA Approval of Additional Indication for Vyxeos (daunorubicin and cytarabine) for the Treatment of Secondary Acute Myeloid Leukemia in Pediatric Patients

DUBLIN, March 30, 2021 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) approved a revised label for Vyxeos® (daunorubicin and cytarabine) to include a new indication to treat newly-diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC) in pediatric patients aged one year and older. The approval of Vyxeos for this indication… Read More »

Spring Clean Your Life

“’Tis the gift to be simple, ’tis the gift to be free,’” proclaims the old Shaker hymn, “Simple Gifts.” And who wouldn’t like a little more simplicity? You can have it now by clearing out things that complicate your life. Start with these: Tune Out Media saturates our lives and can over-stimulate or even depress… Read More »

InterSystems signs on to HL7’s Vulcan FHIR Accelerator Program

InterSystems this week announced that it would join the Vulcan FHIR Accelerator Program, which was recently convened by Health Level Seven International to enable greater interoperability for clinical researchers.   WHY IT MATTERSThe company joins government and regulatory agencies, standards development groups, academic institutions, life sciences and tech vendors and others. The goal of the… Read More »

FDA Approves Roszet (rosuvastatin and ezetimibe) to Reduce LDL-C in Hyperlipidemia and Homozygous Familial Hypercholesterolemia

FDA Approves Roszet (rosuvastatin and ezetimibe) to Reduce LDL-C in Hyperlipidemia and Homozygous Familial Hypercholesterolemia Morristown, N.J. March 31, 2021 — Althera Pharmaceuticals, a company focused on heart health, today announced the FDA approval of Roszet (rosuvastatin and ezetimibe) tablets, as an adjunct to diet, for treatment of elevated low-density lipoprotein cholesterol (LDL-C) in adult… Read More »